CD4 and cancer: The relevance of CD4+ Tregs in suppressing the anti-tumor immune response is well documented, and numerous studies have reported that the accumulation of Tregs in cancer patients is generally associated with tumor progression, a poor prognosis and the suppression of anti-tumor immunity [2, 3].